ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value

AI Briefing

• – ENDRA Life Sciences initiates review of strategic alternatives to maximize shareholder value
• – Company's Board of Directors evaluating range of potential alternatives
• – Process aims to maximize shareholder value